Ann Pediatr Endocrinol Metab.  2012 Mar;17(1):10-15. 10.6065/apem.2012.17.1.10.

Insulin-Like Growth Factor 1 Actions in Developing Brain and the Interaction with Wnt Pathway

Affiliations
  • 1Department of Pediatrics, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea. gnoygnoes@hanmail.net

Abstract

Insulin like growth factor (IGF)-1 signaling through type 1 IGF receptor (IGF1R) is essential to the normal growth and development of the central nervous system. IGF-1 stimulates proliferation of neural stem cells and neural progenitors. IGF-1 also promotes survival and differentiation of neurons and oligodendrocytes, including neuritic outgrowth, synaptogenesis, and myelin production. The phosphatidylinositol 3 kinase (PI3)-Akt pathway and mitogen-activated protein (MAP) kinase pathway are two predominant mediators of IGF1-IGF1R signaling in neural cells. beta-catenin, a key molecule of the canonical Wnt signaling pathway, is also a downstream target of PI3-Akt-glycogen synthase kinase 3beta (GSK3beta) pathway. IGF-1 signaling through IGF1R interacts with canonical Wnt pathway at the levels of GSK3beta and beta-catenin rather than at the levels of Wnt ligands and Frizzled receptors to promote neural proliferation in developing central nervous system.

Keyword

Insulin-like growth factor I; Type 1 IGF receptor; Wnt proteins; Beta catenin; Central nervous system

MeSH Terms

beta Catenin
Brain
Central Nervous System
Frizzled Receptors
Glycogen Synthase Kinase 3
Growth and Development
Insulin
Insulin-Like Growth Factor I
Ligands
Myelin Sheath
Neural Stem Cells
Neurons
Oligodendroglia
Phosphatidylinositol 3-Kinase
Phosphotransferases
Wnt Proteins
Wnt Signaling Pathway
Frizzled Receptors
Glycogen Synthase Kinase 3
Insulin
Insulin-Like Growth Factor I
Ligands
Phosphatidylinositol 3-Kinase
Phosphotransferases
Wnt Proteins
beta Catenin
Full Text Links
  • APEM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr